Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Juvenile Myelomonocytic Leukemia (JMML) Risk Stratification Gene Panel is typically within 14-21 days.

What are the prerequisites for the test Juvenile Myelomonocytic Leukemia (JMML) Risk Stratification Gene Panel

  • Peripheral Blood: 3-5 mL in EDTA tube
  • Bone Marrow: 1-2 mL in EDTA tube
  • Refrigerate specimen
  • Specimen should be collected prior to initiation of treatment
  • Patient history and clinical information
  • Test requisition form

What are the measure values for the test Juvenile Myelomonocytic Leukemia (JMML) Risk Stratification Gene Panel

  1. NRAS Gene Mutation
  2. KRAS Gene Mutation
  3. PTPN11 Gene Mutation
  4. CBL Gene Mutation
  5. SETBP1 Gene Mutation
  6. ASXL1 Gene Mutation
  7. EZH2 Gene Mutation

What does this test Juvenile Myelomonocytic Leukemia (JMML) Risk Stratification Gene Panel identify?

Test Juvenile Myelomonocytic Leukemia (JMML) Risk Stratification Gene Panel

This test identifies mutations in specific genes that are associated with Juvenile Myelomonocytic Leukemia (JMML) and helps in risk stratification of patients with this disease. The gene panel includes analysis of genes such as:

  • NRAS
  • KRAS
  • PTPN11
  • FLT3
  • CBL
  • SOS1
  • NF1

These genes are known to play a role in the development and progression of JMML. By identifying mutations in these genes, healthcare providers can better understand the prognosis of the disease and tailor treatment plans accordingly.

Why is this test Juvenile Myelomonocytic Leukemia (JMML) Risk Stratification Gene Panel taken?

The Juvenile Myelomonocytic Leukemia (JMML) Risk Stratification Gene Panel test is taken to help determine the risk of developing JMML in children. JMML is a rare form of leukemia that typically affects children under the age of 4. This test analyzes specific genes that are known to be associated with JMML, such as NRAS, KRAS, and PTPN11.

By identifying mutations in these genes, healthcare providers can assess the likelihood of JMML development and tailor treatment plans accordingly. This test is crucial for early detection and personalized care for children at risk of JMML.

No FAQs available.

Customer Google Rating